David Lieberman, MD, PhD, provides an overview of Rett Syndrome, explores the patient perspective of Rett Syndrome, and discusses methods clinicians and payers use to evaluate treatment successes.
December 13th 2022EP. 6: Clinical Trials Examining Rett Syndrome
David Lieberman, MD, PhD, discusses the results of the phase 3 LAVENDER trial of trofinetide and the phase 3 AVATAR trial of blarcamesine and how patients and families can learn about eligible clinical trials for possible participation.